Vbiosci focused on the R&D, manufacturing, and commercialization of high-end veterinary biological products. The company has established proprietary subunit and genetic engineering vaccine technologies, with a development pipeline spanning poultry, livestock, and companion animals. Its subsidiary, YSK BIOSCIENCES CO., LTD., independently develops and manufactures key production materials, including serum-free media, purified excipients, and novel adjuvants.
